Contraceptive Drugs and Devices Market By Product (Oral, Topical, Vaginal Contraceptive Drugs, Male Contraceptive Devices, Condoms, Female Contraceptive Devices, Diaphragms, Intra-uterine Devices, Sub-Dermal Implants, Vaginal Rings) Analysis And Segment Forecasts To 2020

Report ID: 978-1-68038-032-3
Number of Pages: 96
Format: Electronic (PDF)

Historical Data: 2011-2013
Industry: Healthcare

Table of Contents

Chapter 1. Executive Summary
1.1. Contraceptive - Industry Summary & Critical Success Factors (CSFs)
Chapter 2. Contraceptive Industry Outlook
  2.1. Market Segmentation
  2.2. Market Size and Growth Prospects
  2.3. Contraceptive Market Dynamics
  2.3.1. Market Driver Analysis
  2.3.2. Market Restraint Analysis
  2.4. Key Opportunities Prioritized
  2.5. Industry Analysis - Porter's
  2.6. Contraceptive - Company Market Share Analysis, 2013
  2.7. Contraceptive market PESTEL Analysis, 2013
Chapter 3. Contraceptive Product Outlook
  3.1. Contraceptive Drugs
  3.1.1. Global Contraceptive drugs demand by region, 2012 - 2020 (USD Million)
  3.1.2. Global oral contraceptive pills demand, 2012 - 2020 (USD million)
  3.1.3. Global Topical contraceptives demand, 2012 - 2020 (USD million)
  3.1.4. Global contraceptive injectables demand, 2012 - 2020 (USD million)
  3.2. Male Contraceptive Devices (Condoms)
  3.2.1. Global Contraceptive devices by region, 2012 - 2020 (USD Million)
  3.3. Female Contraceptive Devices
  3.3.1. Global Female Contraceptive devices demand by region, 2012 - 2020 (USD Million)
  3.3.2. Global female condoms demand, 2012 - 2020 (USD Million)
  3.3.3. Global diaphragms demand, 2012 - 2020 (USD Million)
  3.3.4. Global contraceptive sponges demand, 2012 - 2020 (USD Million)
  3.3.5. Global IUD demand, 2012 - 2020 (USD Million)
  3.3.5.1. Global copper IUD demand, 2012 - 2020 (USD million)
  3.3.5.2. Global hormonal IUD demand, 2012 - 2020 (USD million)
  3.3.6. Global subdermal implants demand, 2012 - 2020 (USD million)
  3.3.7. Global vaginal rings demand, 2012 - 2020 (USD million)
Chapter 4. Contraceptive Regional Outlook
  4.1. North America
  4.1.1. North America Contraceptive market revenue by product, 2012 - 2020 (USD Million)
  4.2. Europe
  4.2.1. Europe Contraceptive market revenue by product, 2012 - 2020 (USD Million)
  4.3. Asia Pacific
  4.3.1. Asia Pacific Contraceptive market revenue by product, 2012 - 2020 (USD Million)
  4.4. RoW
  4.4.1.RoW Contraceptive market revenue by product, 2012 - 2020 (USD Million)
Chapter 5 Competitive Landscape
                5.1 Agile Therapeutics Inc.
                    5.1.1 Company Overview
                    5.1.2 Financial Performance
                    5.1.3 Product Benchmarking
                    5.1.4 Strategic Initiatives
                5.2 Bayer Healthcare AG
                    5.2.1 Company Overview
                    5.2.2 Financial Performance
                    5.2.3 Product Benchmarking
                    5.2.4 Strategic Initiatives
                5.3 BioSante Pharmaceuticals Inc.
                    5.3.1 Company Overview
                    5.3.2 Financial Performance
                    5.3.3 Product Benchmarking
                    5.3.4 Strategic Initiatives
                5.4 Church & Dwight Co. Inc.
                    5.4.1 Company Overview
                    5.4.2 Financial Performance
                    5.4.3 Product Benchmarking
                    5.4.4 Strategic Initiatives
                5.5 Mayer Laboratories Inc.
                    5.5.1 Company Overview
                    5.5.2 Financial Performance
                    5.5.3 Product Benchmarking
                    5.5.4 Strategic Initiatives
                5.6 Merck & Co.
                    5.6.1 Company Overview
                    5.6.2 Financial Performance
                    5.6.3 Product Benchmarking
                    5.6.4 Strategic Initiatives
                5.7 Pantarhei Bioscience B.V.
                    5.7.1 Company Overview
                    5.7.2 Financial Performance
                    5.7.3 Product Benchmarking
                    5.7.4 Strategic Initiatives
                5.8 Pfizer Inc.
                    5.8.1 Company Overview
                    5.8.2 Financial Performance
                    5.8.3 Product Benchmarking
                    5.8.4 Strategic Initiatives
                5.9 Teva Pharmaceutical Industries Ltd.
                    5.9.1 Company Overview
                    5.9.2 Financial Performance
                    5.9.3 Product Benchmarking
                    5.9.4 Strategic Initiatives
                5.10 Warner Chilcott Company Inc.
                    5.10.1 Company Overview
                    5.10.2 Financial Performance
                    5.10.3 Product Benchmarking
                    5.10.4 Strategic Initiatives
Chapter 6.  Methodology and Scope
  6.1. Research Methodology
  6.2. Research Scope & Assumption
  6.3. List of Data Sources

List of Tables

1. Contraceptive - Industry Summary & Critical Success Factors (CSFs)
2. Global Contraceptive market(USD Million), 2012 - 2020
3. Global Contraceptive market by region, 2012 - 2020 (USD Million)
4. Global Contraceptive Drugs demand, 2012 - 2020 (USD Million)
5. Global Male Contraceptive Devices (Condoms) demand, 2012 - 2020 (USD Million)
6. Global Female Contraceptive Devices demand by Product, 2012 - 2020 (USD Million)
7. Global Female Condoms demand, 2012 - 2020 (USD Million)
8. Global Diaphragms demand by Product, 2012 - 2020 (USD Million)
9. Global Sponges demand, 2012 - 2020 (USD Million)
10. Global Intra-uterine Devices demand, 2012 - 2020 (USD Million)
11. Global Hormonal IUDs demand, 2012 - 2020 (USD Million)
12. Global Copper IUDs demand, 2012 - 2020 (USD Million)
13. Global Sub-dermal Contraceptive Implants demand, 2012 - 2020 (USD Million)
14. Global Vaginal Rings demand, 2012 - 2020 (USD Million)
15. North America Contraceptive market by product, 2012 - 2020 (USD Million)
16. Europe Contraceptive market by product, 2012 - 2020 (USD Million)
17. Asia Pacific Contraceptive market by product, 2012 - 2020 (USD Million)
18. RoW Contraceptive market by product, 2012 - 2020 (USD Million)

List of Figures

1. Contraceptive Market Segmentation
2. Global Contraceptive Market 2012 - 2020 (USD Million)
3. Contraceptive value chain analysis
4. Contraceptive market dynamics
5. Contraceptive - Company market share analysis, 2013
6. Key Opportunities Prioritized
7. Industry Analysis - Porter's
8. Contraceptive PESTEL Analysis, 2013
9. Contraceptive market share by product, 2012 & 2020
10. Global Contraceptive Drugs demand 2012 - 2020 (USD Million)
11. Global Male Contraceptive Devices demand, 2012 - 2020 (USD Million)
12. Global Female Contraceptive Devices demand, 2012 - 2020 (USD Million)
13. Contraceptive market share by region, 2012 & 2020
14. North America Contraceptive market, by product 2012 - 2020 (USD Million)
15. Europe Contraceptive market, by product 2012 - 2020 (USD Million)
16. Asia Pacific Contraceptive market, by product 2012 - 2020 (USD Million)
17. RoW Contraceptive market, by product 2012 - 2020 (USD Million)

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.